Small Molecules for cell reprogramming and heart repair: Progress and perspective

ACS Chemical Biology

Volumn 9, Issue 1, 2014, Pages 34-44

  Xie, Min ^a   Cao, Nan ^a   Ding, Sheng ^a  

^a GLADSTONE INSTITUTES   (United States)

Author keywords

Cardiac regeneration; Cell reprogramming; Differentiation; PSC; Signaling pathway; Small molecule; TF; Transdifferentiation

Indexed keywords

MOLECULAR THERAPY AGENT;

CARDIAC MUSCLE CELL; CARDIAC STEM CELL; CELL DEDIFFERENTIATION; CELL HETEROGENEITY; CELL PROLIFERATION; HEART GRAFT; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; TISSUE REPAIR;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; HEART; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; PLURIPOTENT STEM CELLS; REGENERATION; REGENERATIVE MEDICINE; SMALL MOLECULE LIBRARIES;

EID: 84900445950     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb400865w     Document Type: Review

References (107)

1. Harvey, P. A., and Leinwand, L. A. (2011) The cell biology of disease: cellular mechanisms of cardiomyopathy. J. Cell Biol. 194, 355-365.
2. Passier, R., van Laake, L. W., and Mummery, C. L. (2008) Stemcell-based therapy and lessons from the heart. Nature 453, 322-329.
3. Burridge, P. W., Keller, G., Gold, J. D., and Wu, J. C. (2012) Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10, 16-28.
4. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., and Waknitz., M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147.
5. Takahashi, K., and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676.
6. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872.
7. Yu, J., and Vodyanik., M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., and Thomson, J. A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920.
8. Yamanaka, S. (2007) Strategies and new developments in the generation of patient specific pluripotent stem cells. Cell Stem Cell 1, 39-49.
9. Merkle, F. T., and Eggan, K. (2013) Modeling human disease with pluripotent stem cells: from genome association to function. Cell Stem Cell 12, 656-668.
10. Engle, S. J., and Puppala, D. (2013) Integrating human pluripotent stem cells into drug development. Cell Stem Cell 12, 669-677.
11. Hong, S. G., and Dunbar., C. E., and Winkler, T. (2013) Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells. Mol. Ther. 2, 272-281.
12. Frye, S. V. (2010) The art of the chemical probe. Nat. Chem. Biol. 6, 159-161.
13. Li, W., Li, K., Wei, W., and Ding, S. (2013) Chemical approaches to stem cell biology and therapeutics. Cell Stem Cell 13, 270-283.
14. Nie, B., Wang, H., Laurent, T., and Ding, S. (2012) Cellular reprogramming: a small molecule perspective. Curr. Opin. Cell Biol. 24, 784-792.
15. Lyssiotis, C. A., and Lairson., L. L., Boitano, A. E., Wurdak, H., Zhu, S., and Schultz, P. G. (2011) Chemical control of stem cell fate and developmental potential. Angew. Chem., Int. Ed. 50, 200-242.
16. Hawkins, R. D., and Hon., G. C., Lee, L. K., Ngo, Q., Lister, R., Pelizzola, M., Edsall, L. E., Kuan, S., Luu, Y., Klugman, S., Antosiewicz-Bourget, J., Ye, Z., Espinoza, C., Agarwahl, S., Shen, L., Ruotti, V., Wang, W., Stewart, R., and Thomson., J. A., Ecker, J. R., and Ren, B. (2010) Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6, 479-491.
17. Spivakov, M., and Fisher, A. G. (2007) Epigenetic signatures of stem-cell identity. Nat. Rev. Genet. 8, 263-271.
18. Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., Plath, K., and Hochedlinger, K. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55-70.
19. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., and Lander., E. S., and Meissner, A. (2008) Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49-55.
20. Meshorer, E., and Misteli, T. (2006) Chromatin in pluripotent embryonic stem cells and differentiation. Nat. Rev. Mol. Cell Biol. 7, 540-546.
21. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12, 599-606.
22. Kretsovali, A., Hadjimichael, C., and Charmpilas, N. (2012) Histone deacetylase inhibitors in cell pluripotency, differentiation, and reprogramming. Stem Cells Int. 2012, 184154.
23. Huangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., and Melton, D. A. (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26, 795-797.
24. Knoepfler, P. S., and Zhang., X. Y., Cheng, P. F., Gafken, P. R., and McMahon., S. B., and Eisenman, R. N. (2006) Myc influences global chromatin structure. EMBO J. 25, 2723-2734.
25. Meshorer, E., Yellajoshula, D., George, E., Scambler, P. J., and Brown., D. T., and Misteli, T. (2006) Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells. Dev. Cell 10, 105-116.
26. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., and Yamanaka, S. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106.
27. Wernig, M., Meissner, A., Cassady, J. P., and Jaenisch, R. (2008) c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2, 10-12.
28. Huangfu, D., Osafune, K., Maehr, R., Guo, W., Eijkelenboom, A., Chen, S., Muhlestein, W., and Melton, D. A. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 26, 1269-1275.
29. Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., Kelly, T. A., and Jenuwein, T. (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol. Cell 25, 473-481.
30. Shi, Y., Desponts, C., Do, J. T., and Hahm., H. S., Scholer, H. R., and Ding, S. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574.
31. Shi, Y., and Do., J. T., Desponts, C., Hahm, H. S., and Scholer., H. R., and Ding, S. (2008) A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2, 525-528.
32. Chen, X., Xu, H., Yuan, P., Fang, F., Huss, M., Vega, V. B., Wong, E., and Orlov., Y. L., Zhang, W., Jiang, J., Loh, Y. H., and Yeo., H. C., Yeo, Z. X., Narang, V., Govindarajan, K. R., Leong, B., Shahab, A., Ruan, Y., Bourque, G., and Sung., W. K., Clarke, N. D., Wei, C. L., and Ng, H. H. (2008) Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106-1117.
33. Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., Qin, B., Xu, J., Li, W., Yang, J., Gan, Y., Qin, D., Feng, S., Song, H., Yang, D., Zhang, B., Zeng, L., Lai, L., and Esteban., M. A., and Pei, D. (2010) A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7, 51-63.
34. Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., Lin, X., and Hahm., H. S., Hao, E., Hayek, A., and Ding, S. (2009) A chemical platform for improved induction of human iPSCs. Nat. Methods 6, 805-808.
35. Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., and Chung., J. E., Egli, D., Loh, K. M., and Carter., A. C., Di Giorgio, F. P., Koszka, K., Huangfu, D., Akutsu, H., Liu, D. R., Rubin, L. L., and Eggan, K. (2009) A small-molecule inhibitor of TGF-β signaling replaces Sox2 in reprogramming by inducing nanog. Cell Stem Cell 5, 491-503.
36. Maherali, N., and Hochedlinger, K. (2009) Tgfβ signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr. Biol. 19, 1718-1723.
37. Yuan, X., Wan, H., Zhao, X., Zhu, S., Zhou, Q., and Ding, S. (2011) Brief report: Combined chemical treatment enables oct4-induced reprogramming from mouse embryonic fibroblasts. Stem Cells 29, 549-553.
38. Reya, T., and Clevers, H. (2005) Wnt signalling in stem cells and cancer. Nature 434, 843-850.
39. Li, W., Zhou, H., Abujarour, R., Zhu, S., and Young., J. J., Lin, T., Hao, E., Scholer, H. R., Hayek, A., and Ding, S. (2009) Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells 27, 2992-3000.
40. Lyssiotis, C. A., and Foreman., R. K., Staerk, J., Garcia, M., Mathur, D., Markoulaki, S., Hanna, J., Lairson, L. L., and Charette., B. D., Bouchez, L. C., Bollong, M., Kunick, C., Brinker, A., Cho, C. Y., and Schultz., P. G., and Jaenisch, R. (2009) Reprogramming of murine fibroblasts to induced pluripotent stem cells with chemical complementation of Klf4. Proc. Natl. Acad. Sci. U.S.A. 106, 8912-8917.
41. Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., Kim, J., Zhang, K., and Ding, S. (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell 7, 651-655.
42. Hou, P., Li, Y., Zhang, X., Liu, C., Guan, J., Li, H., Zhao, T., Ye, J., Yang, W., Liu, K., Ge, J., Xu, J., Zhang, Q., Zhao, Y., and Deng, H. (2013) Science 341, 651-654.
43. Li, Y., Zhang, Q., Yin, X., Yang, W., Du, Y., Hou, P., Ge, J., Liu, C., Zhang, W., Zhang, X., Wu, Y., Li, H., Liu, K., Wu, C., Song, Z., Zhao, Y., Shi, Y., and Deng, H. (2011) Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules. Cell Res. 21, 196-204.
44. Miranda, T. B., and Cortez., C. C., Yoo, C. B., Liang, G., Abe, M., and Kelly., T. K., Marquez, V. E., and Jones, P. A. (2009) DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer. Ther. 8, 1579-1588.
45. Odorico, J. S., and Kaufman., D. S., and Thomson, J. A. (2001) Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19, 193-204.
46. Abbasalizadeh, S., and Baharvand, H. (2013) Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies. Biotechnol. Adv. 31, 1600-1623.
47. Amit, M., Margulets, V., Segev, H., Shariki, K., Laevsky, I., Coleman, R., and Itskovitz-Eldor, J. (2003) Human feeder layers for human embryonic stem cells. Biol. Reprod. 68, 2150-2156.
48. Ludwig, T. E., and Levenstein., M. E., Jones, J. M., Berggren, W. T., and Mitchen., E. R., Frane, J. L., Crandall, L. J., and Daigh., C. A., Conard, K. R., Piekarczyk, M. S., and Llanas., R. A., and Thomson, J. A. (2006) Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185-187.
49. Ludwig, T. E., Bergendahl, V., Levenstein, M. E., Yu, J., and Probasco., M. D., and Thomson, J. A. (2006) Feeder-independent culture of human embryonic stem cells. Nat. Methods 3, 637-646.
50. Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S., Muguruma, K., and Sasai, Y. (2007) A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat. Biotechnol. 25, 681-686.
51. Chen, L., and Khillan, J. S. (2008) Promotion of feeder-independent self-renewal of embryonic stem cells by retinol (vitamin A). Stem Cells 26, 1858-1864.
52. Xu, Y., Zhu, X., Hahm, H. S., Wei, W., Hao, E., Hayek, A., and Ding, S. (2010) Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc. Natl. Acad. Sci. U.S.A. 107, 8129-8134.
53. Chen, G., and Gulbranson., D. R., Hou, Z., Bolin, J. M., Ruotti, V., and Probasco., M. D., Smuga-Otto, K., Howden, S. E., and Diol., N. R., Propson, N. E., Wagner, R., Lee, G. O., Antosiewicz-Bourget, J., Teng, J. M., and Thomson, J. A. (2011) Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424-429.
54. Beers, J., and Gulbranson., D. R., George, N., Siniscalchi, L. I., Jones, J., and Thomson., J. A., and Chen, G. (2012) Passaging and colony expansion of human pluripotent stem cells by enzyme-free dissociation in chemically defined culture conditions. Nat. Protoc. 7, 2029-2040.
55. Kehat, I., Kenyagin-Karsenti, D., Snir, M., Segev, H., Amit, M., and Gepstein, A. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108, 407-414.
56. Zwi, L., Caspi, O., Arbel, G., Huber, I., Gepstein, A., Park, I. H., and Gepstein, L. (2009) Cardiomyocyte differentiation of human induced pluripotent stem cells. Circulation 120, 1513-1523.
57. Takahashi, T., Lord, B., Schulze, P. C., and Fryer., R. M., Sarang, S. S., Gullans, S. R., and Lee, R. T. (2003) Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes. Circulation 107, 1912-1916.
58. Cao, N., Liu, Z., Chen, Z., Wang, J., Chen, T., Zhao, X., Ma, Y., Qin, L., Kang, J., Wei, B., Wang, L., Jin, Y., and Yang, H.-T. (2012) Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res. 22, 219-236.
59. Wu, X., Ding, S., Ding, Q., Gray, N. S., and Schultz, P. G. (2004) Small molecules that induce cardiomyogenesis in embryonic stem cells. J. Am. Chem. Soc. 126, 590-591.
60. Wei, Z. L., and Petukhov., P. A., Bizik, F., Teixeira, J. C., Mercola, M., and Volpe., E. A., Glazer, R. I., Willson, T. M., and Kozikowski, A. P. (2004) Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation. J. Am. Chem. Soc. 126, 16714-16715.
61. Sachinidis, A., Schwengberg, S., Hippler-Altenburg, R., Mariappan, D., Kamisetti, N., Seelig, B., Berkessel, A., and Hescheler, J. (2006) Identification of small signalling molecules promoting cardiac-specific differentiation of mouse embryonic stem cells. Cell. Physiol. Biochem. 18, 303-314.
62. Graichen, R., Xu, X., Braam, S. R., Balakrishnan, T., Norfiza, S., Sieh, S., Soo, S. Y., and Tham., S. C., Mummery, C., Colman, A., Zweigerdt, R., and Davidson, B. P. (2008) Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation 76, 357-370.
63. Sadek, H., Hannack, B., Choe, E., Wang, J., Latif, S., Garry, M. G., and Garry., D. J., Longgood, J., Frantz, D. E., and Olson., E. N., Hsieh, J., and Schneider, J. W. (2008) Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc. Natl. Acad. Sci. U.S.A. 105, 6063-6068.
64. Berkessel, A., Seelig, B., Schwengberg, S., Hescheler, J., and Sachinidis, A. (2010) Chemically induced cardiomyogenesis of mouse embryonic stem cells. ChemBioChem 11, 208-217.
65. Hao, J., and Daleo., M. A., Murphy, C. K., Yu, P. B., and Ho., J. N., Hu, J., Peterson, R. T., and Hatzopoulos., A. K., and Hong, C. C. (2008) Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells. PLoS One 3, e2904.
66. Kattman, S. J., and Witty., A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., and Keller, G. (2011) Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228-240.
67. Willems, E., Cabral-Teixeira, J., Schade, D., Cai, W., Reeves, P., Bushway, P. J., Lanier, M., Walsh, C., Kirchhausen, T., Izpisua Belmonte, J. C., Cashman, J., and Mercola, M. (2012) Small molecule-mediated TGF-β type II receptor degradation promotes cardiomyo-genesis in embryonic stem cells. Cell Stem Cell 11, 242-252.
68. Naito, A. T., Shiojima, I., Akazawa, H., Hidaka, K., Morisaki, T., Kikuchi, A., and Komuro, I. (2006) Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis. Proc. Natl. Acad. Sci. U.S.A. 103, 19812-19817.
69. Willems, E., Spiering, S., Davidovics, H., Lanier, M., Xia, Z., Dawson, M., Cashman, J., and Mercola, M. (2011) Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm. Circ. Res. 109, 360-364.
70. Wang, H., Hao, J., and Hong, C. C. (2011) Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/betacatenin signaling. ACS Chem. Biol. 6, 192-197.
71. Gonzalez, R., and Lee., J. W., and Schultz, P. G. (2011) Stepwise chemically induced cardiomyocyte specification of human embryonic stem cells. Angew. Chem., Int. Ed. 50, 11181-11185.
72. Lian, X., Hsiao, S., Wilson, G., Zhu, K., and Hazeltine., L. B., Azarin, S. M., Raval, K., Zhang, J., and Kamp., T. J., and Palecek, S. P. (2012) Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. U.S.A. 109, E1848-E1857.
73. Minami, I., Yamada, K., Otsuji, T. G., Yamamoto, T., Shen, Y., Otsuka, S., Kadota, S., Morone, N., Barve, M., Asai, Y., Tenkova-Heuser, T., Heuser, J. E., Uesugi, M., Aiba, K., and Nakatsuji, N. (2012) A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions. Cell Rep. 2, 1448-1160.
74. Kleger, A., Seufferlein, T., Malan, D., Tischendorf, M., Storch, A., Wolheim, A., Latz, S., Protze, S., Porzner, M., Proepper, C., Brunner, C., Katz, S. F., and Pusapati., G. V., Bullinger, L., Franz, W. M., Koehntop, R., Giehl, K., Spyrantis, A., Wittekindt, O., Lin, Q., Zenke, M., Fleischmann, B. K., Wartenberg, M., and Wobus., A. M., Boeckers, T. M., and Liebau, S. (2010) Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation 122, 1823-1836.
75. Zhu, W. Z., Xie, Y., Moyes, K. W., and Gold., J. D., Askari, B., and Laflamme, M. A. (2010) Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ. Res. 107, 776-786.
76. Zhang, Q., Jiang, J., Han, P., Yuan, Q., Zhang, J., Zhang, X., Xu, Y., Cao, H., Meng, Q., Chen, L., Tian, T., Wang, X., Li, P., Hescheler, J., Ji, G., and Ma, Y. (2011) Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res. 21, 579-587.
77. Laflamme, M. A., and Chen., K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., and Dupras., S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., O'Sullivan, C., Collins, L., Chen, Y., Minami, E., Gill, E. A., Ueno, S., Yuan, C., Gold, J., and Murry, C. E. (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25, 1015-1024.
78. Shiba, Y., Fernandes, S., Zhu, W.-Z., Filice, D., Muskheli, V., Kim, J., Palpant, N. J., Gantz, J., and Moyes., K. W., Reinecke, H., Van Biber, B., Dardas, T., Mignone, J. L., Izawa, A., Hanna, R., Viswanathan, M., Gold, J. D., and Kotlikoff., M. I., Sarvazyan, N., Kay, M. W., and Murry., C. E., and Laflamme, M. A. (2012) Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts. Nature 489, 322-325.
79. Zhang, M., Methot, D., Poppa, V., Fujio, Y., Walsh, K., and Murry, C. E. (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell Cardiol. 33, 907-921.
80. van Laake, L. W., Passier, R., Monshouwer-Kloots, J., Verkleij, A. J., and Lips., D. J., Freund, C., den Ouden, K., Ward-van Oostwaard, D., Korving, J., Tertoolen, L. G., van Echteld, C. J., Doevendans, P. A., and Mummery, C. L. (2007) Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1, 9-24.
81. Niagara, M. I., Haider, H.-K., Jiang, S., and Ashraf, M. (2007) Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ. Res. 100, 545-555.
82. Shinmura, D., Togashi, I., Miyoshi, S., Nishiyama, N., Hida, N., Tsuji, H., Tsuruta, H., Segawa, K., Tsukada, Y., Ogawa, S., and Umezawa, A. (2011) Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function. Stem Cells 29, 357-366.
83. Braam, S. R., Nauw, R., Ward-van Oostwaard, D., Mummery, C., and Passier, R. (2010) Inhibition of ROCK improves survival of human embryonic stem cell-derived cardiomyocytes after dissociation. Ann. N.Y. Acad. Sci. 1188, 52-67.
84. Yeghiazarians, Y., Gaur, M., Zhang, Y., Sievers, R. E., Ritner, C., Prasad, M., Boyle, A., and Bernstein, H. S. (2012) Myocardial improvement with human embryonic stem cell-derived cardiomyo-cytes enriched by p38MAPK inhibition. Cytotherapy 14, 223-231.
85. Davis, M. E., and Hsieh., P. C., Takahashi, T., Song, Q., Zhang, S., and Kamm., R. D., Grodzinsky, A. J., Anversa, P., and Lee, R. T. (2006) Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 103, 8155-8160.
86. Singla, D. K., and Singla., R. D., Lamm, S., and Glass, C. (2011) TGF-β2 treatment enhances cytoprotective factors released from embryonic stem cells and inhibits apoptosis in infarcted myocardium. Am. J. Physiol. Heart Circ. Physiol. 300, H1442-H1450.
87. Robey, T. E., and Saiget., M. K., Reinecke, H., and Murry, C. E. (2008) Systems approaches to preventing transplanted cell death in cardiac repair. J. Mol. Cell Cardiol. 45, 567-581.
88. Ahuja, P., Sdek, P., and MacLellan, W. R. (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 87, 521-544.
89. Xin, M., and Olson., E. N., and Bassel-Duby, R. (2013) Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair. Nat. Rev. Mol. Cell Biol. 14, 529-541.
90. Bergmann, O., and Bhardwaj., R. D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., Jovinge, S., and Frisen, J. (2009) Evidence for cardiomyocyte renewal in humans. Science 324, 98-102.
91. Kajstura, J., Urbanek, K., Perl, S., Hosoda, T., Zheng, H., Ogorek, B., Ferreira-Martins, J., Goichberg, P., Rondon-Clavo, C., Sanada, F., D'Amario, D., Rota, M., Del Monte, F., Orlic, D., Tisdale, J., Leri, A., and Anversa, P. (2010) Cardiomyogenesis in the adult human heart. Circ. Res. 107, 305-315.
92. Senyo, S. E., and Steinhauser., M. L., Pizzimenti, C. L., Yang, V. K., Cai, L., Wang, M., Wu, T. D., Guerquin-Kern, J. L., Lechene, C. P., and Lee, R. T. (2013) Mammalian heart renewal by pre-existing cardiomyocytes. Nature 493, 433-436.
93. Pasumarthi, K. B., Nakajima, H., Nakajima, H. O., and Soonpaa., M. H., and Field, L. J. (2005) Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice. Circ. Res. 96, 110-118.
94. Eulalio, A., Mano, M., Dal Ferro, M., Zentilin, L., Sinagra, G., Zacchigna, S., and Giacca, M. (2012) Functional screening identifies miRNAs inducing cardiac regeneration. Nature 492, 376-381.
95. Engel, F. B., and Hsieh., P. C., Lee, R. T., and Keating, M. T. (2006) FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction. Proc. Natl. Acad. Sci. U.S.A. 103, 15546-15551.
96. Uosaki, H., Magadum, A., Seo, K., Fukushima, H., Takeuchi, A., Nakagawa, Y., Moyes, K. W., Narazaki, G., Kuwahara, K., Laflamme, M., Matsuoka, S., Nakatsuji, N., Nakao, K., Kwon, C., and Kass., D. A., Engel, F. B., and Yamashita, J. K. (2013) Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells. Circ. Cardiovasc. Genet. 6, 624-633.
97. Baudino, T. A., Carver, W., Giles, W., and Borg, T. K. (2006) Cardiac fibroblasts: friend or foe? Am. J. Physiol. Heart Circ. Physiol. 291, H1015-H1026.
98. Ieda, M., Fu, J.-D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., and Srivastava, D. (2010) Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386.
99. Efe, J. A., Hilcove, S., Kim, J., Zhou, H., Ouyang, K., Wang, G., Chen, J., and Ding, S. (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol. 13, 215-222.
100. Jayawardena, T. M., Egemnazarov, B., Finch, E. A., Zhang, L., and Payne., J. A., Pandya, K., Zhang, Z., Rosenberg, P., Mirotsou, M., and Dzau, V. J. (2012) MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circ. Res. 110, 1465-1473.
101. Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., and Srivastava, D. (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyo-cytes. Nature 485, 593-598.
102. Song, K., and Nam., Y. J., Luo, X., Qi, X., Tan, W., and Huang., G. N., Acharya, A., Smith, C. L., and Tallquist., M. D., Neilson, E. G., Hill, J. A., Bassel-Duby, R., and Olson, E. N. (2012) Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485, 599-604.
103. Sturzu, A. C., and Wu, S. M. (2011) Developmental and regenerative biology of multipotent cardiovascular progenitor cells. Circ. Res. 108, 353-364.
104. Loffredo, F. S., and Steinhauser., M. L., Gannon, J., and Lee, R. T. (2011) Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 8, 389-398.
105. Smart, N., Bollini, S., Dube, K. N., and Vieira., J. M., Zhou, B., Davidson, S., Yellon, D., Riegler, J., Price, A. N., and Lythgoe., M. F., Pu, W. T., and Riley, P. R. (2011) De novo cardiomyocytes from within the activated adult heart after injury. Nature 474, 640-644.
106. Zangi, L., and Lui., K. O., von Gise, A., Ma, Q., Ebina, W., and Ptaszek., L. M., Spater, D., Xu, H., Tabebordbar, M., Gorbatov, R., Sena, B., Nahrendorf, M., and Briscoe., D. M., Li, R. A., Wagers, A. J., and Rossi., D. J., Pu, W. T., and Chien, K. R. (2013) Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction. Nat. Biotechnol. 31, 898-907.
107. Russell, J. L., and Goetsch., S. C., Aguilar, H. R., Frantz, D. E., and Schneider, J. W. (2013) Targeting native adult heart progenitors with cardiogenic small molecules. ACS Chem. Biol. 7, 1067-1076.